deltatrials
Completed OBSERVATIONAL NCT05605067

Genetic Architecture of Avoidant/Restrictive Food Intake Disorder (ARFID-GEN)

Sponsor: National Institute of Mental Health (NIMH)

Updated 6 times since 2022 Last updated: Oct 25, 2024 Started: Jan 5, 2023 Primary completion: Aug 1, 2024 Completion: Aug 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05605067, this observational or N/A phase trial focuses on ARFID and Eating Disorders and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshotRecruiting~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Nov 2024 — Present [monthly]

    Completed

  2. Sep 2024 — Nov 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jul 2023 — Jul 2024 [monthly]

    Recruiting

  5. Feb 2023 — Jul 2023 [monthly]

    Recruiting

    Status: Not Yet RecruitingRecruiting

Show 1 earlier version
  1. Dec 2022 — Feb 2023 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
  • Psychiatric Center Ballerup
  • University of North Carolina, Chapel Hill
Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations